A phase II, open, controlled study to evaluate the reactogenicity and the immunogenicity of GlaxoSmithKline Biologicals adjuvanted influenza vaccine in elderly adults previously vaccinated with either Fluarix or the adjuvanted vaccine.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 19 Dec 2006 New trial record.